ASAP - Assisted Immediate Augmented Post-/Long-COVID Plan for Patients Infected With COVID-19 (ASAP)
Long-COVID, Post-COVID, Psychosomatic Disorder
About this trial
This is an interventional health services research trial for Long-COVID focused on measuring Post-COVID, Long-COVID, treatment plan, eHealth, digital intervention, medical rehabilitation, psychosomatic rehabilitation
Eligibility Criteria
Inclusion Criteria:
- All people who are resident in Bavaria can participate. They must be of working age and have the ability to participate in surveys (e.g., sufficient German language skills). A willingness to participate in outpatient or (partially) inpatient therapy, the ability to undergo rehabilitation if necessary, and a telephone and Internet connection are prerequisites. There is a suspicion of post-/long-COVID.
Exclusion Criteria:
- Contraindications regarding physical exercise, not being of age, illiteracy and massively limited cognitive abilities (linguistic components of the digital offerings must be able to be used and questionnaires completed or interviews participated in).
Sites / Locations
- Dr. Becker Klinikgruppe
Arms of the Study
Arm 1
Arm 2
Arm 3
No Intervention
Experimental
No Intervention
Control group receiving no Post-/Long-COVID assessment
Intervention group receiving a Post-/Long-COVID assessment
Comparison group receiving no Post-/Long-COVID assessment
Questionnaires at timepoints t1 (screening), t2 (one week later), t3 (before the intervention), t4 (after the intervention), t5 (6 weeks after intervention), t6 (6 months after the intervention) Patients from Bavaria Germany: Contact to personal pilots and digital health interventions.
Questionnaires at timepoints t1 (screening), t2 (one week later), t3 (before the intervention), t4 (after the intervention), t5 (6 weeks after intervention), t6 (6 months after the intervention) Patients from Bavaria Germany: Assessment in clinics for post-/long-COVID, contact to personal pilots and digital health interventions.
Questionnaires at timepoints t1 (screening), t2 (comparable to t2 in the other groups), t3 (comparable with t4 in the other groups), t3 (comparable to t5 in the other groups) Patients from Germany: No intervention at all